[ Price : $8.95]
A Federation of American Scientists online paper says FDA, other federal research agencies, and Congress should take steps to incr...[ Price : $8.95]
Taiho Pharmaceutical reports disappointing data from its Phase 3 extension study of TAS-205 (pizuglanstat) in patients with Duchen...[ Price : $8.95]
A bioethicists opinion piece in The Hill says FDA needs to expand its reliance on real-world clinical data to monitor the safety a...[ Price : $8.95]
FDA warns Clarksville, TN-based Insightra Medical about multiple violations in its production of intra-aortic balloon pump cathete...[ Price : $8.95]
A new FDA clinical trial finds that cannabidiol may cause liver enzyme elevations in otherwise healthy adults raising new concern...[ Price : $8.95]
FDA approves an expanded indication for Insightecs Exablate Neuro platform for staged bilateral pallidothalamic tractotomy treatme...[ Price : $8.95]
FDA issues a complete response letter to Unicycive Therapeutics for its hyperphosphatemia drug oxylanthanum carbonate that cites i...[ Price : $8.95]
FDA gives accelerated approval to Dizals lung cancer drug Zegfrovy, along with a companion diagnostic device.